Skip to main content

Corporate News tagged:

Genomic Services

Sep 27, 2023

Bioserve Biotechnologies Partners with BioMavericks Ltd. to Expand Presence in the UK market

[Hyderabad, India, 27 September 2023] – Bioserve Biotechnologies (India) Pvt Limited, is teaming up with BioMavericks Ltd., a UK-based company.

Sep 15, 2021

Bioserve India to sponsor webinar hosted by the Society of Fetal Medicine

Find out more about Genetic Testing in Fetal Medicine in the upcoming REPROCELL sponsored webinar by the Society of Fetal Medicine.

Apr 24, 2019

REPROCELL and Hanugen to custom manufacture clinical grade oligos for gene therapy

REPROCELL India and Hanugen Therapeutics have announced the launch of their custom manufacture offering for synthesis of milli molar scale clinical grade oligonucleotides for gene therapy.

Apr 08, 2019

REPROCELL USA Inc. Achieves Quality Management ISO9001:2015 Certification

Find out about REPROCELL USA's recently achieved ISO9001:2015 accreditation. demonstrating its ability to consistently meet customer requirements

Jun 13, 2018

REPROCELL’s footprint extends to serve life sciences in India

Learn more about REPROCELL India's expansion into the life sciences industry through the integration of Oligonucleotide Services and Next Generation Sequencing

Apr 26, 2018

Acquisition of BioServe Biotechnologies India Pvt. Ltd.

REPROCELL announces that it has acquired Bioserve biotechnologies, further expanding REPROCELL's portfolio of service offerings

1